Luca Benatti
Founder bei NEWRON PHARMACEUTICALS S.P.A.
Vermögen: 85 077 $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Luca Benatti
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 48 | |
Public Company | Pharmaceuticals: Major | 26 | |
Public Company | Biotechnology | 13 | |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy.
10
| Subsidiary | Medical Specialties | 10 |
The European Association for Bioindustries
10
| Non-Profit Organization | 10 | |
Metis Precision Medicine Sb Srl
Metis Precision Medicine Sb Srl Miscellaneous Commercial ServicesCommercial Services Metis Precision Medicine Sb SRL develops cancer therapies. The company was founded by Paolo Comoglio, Carla Boccaccio, Elisa Vigna, James Hughes and Beatrice Ramasco in 2017 and is headquartered in Turin, Italy.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Italian Angels For Biotech
Italian Angels For Biotech Investment ManagersFinance Italian Angels For Biotech (IAB) is a venture capital firm founded in 2015. The firm is headquartered in Bresso, Italy.
2
| Private Company | Investment Managers | 2 |
TES Pharma SRL
TES Pharma SRL Medical SpecialtiesHealth Technology TES Pharma SRL provides vitro diagnostics. The private company is based in Corciano, Italy. The Italian company was founded in 2011 by Roberto Pellicciari. Roberto Pellicciari has been the CEO since 2011.
2
| Holding Company | Medical Specialties | 2 |
CaSRevolution SRL
CaSRevolution SRL Miscellaneous Commercial ServicesCommercial Services CaSRevolution SRL provides therapies for neurodegenerative diseases. The Italian company was founded by Gabriele Grecchi.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Luca Benatti
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member General Counsel Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Human Resources Officer | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
CHIMERIX, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
GELESIS INC | Biotechnology | Director/Board Member Chairman | |
HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
CORBION N.V. | Food: Specialty/Candy | Chairman Chief Tech/Sci/R&D Officer | |
STALLERGENES | Pharmaceuticals: Major | Chairman Director/Board Member | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member | |
Fairleigh Dickinson University | College/University | Masters Business Admin Masters Business Admin | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Graduate Degree | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Pavia | College/University | Undergraduate Degree Undergraduate Degree | |
University of Milan | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genextra SpA
Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investment Managers | Corporate Officer/Principal Chief Executive Officer | |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member Chief Executive Officer | |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Director/Board Member | |
The University of North Carolina at Charlotte | College/University | Masters Business Admin Graduate Degree | |
PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Human Resources Officer | |
Duke University School of Law | College/University | Graduate Degree Graduate Degree | |
SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
TERNS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Chief Executive Officer Chief Operating Officer | |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The private company is based in Bristol, UK. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Intercept Pharma UK & Ireland Ltd.
Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the private company is based in Bristol, UK. | Medical Distributors | Director/Board Member Director/Board Member | |
Intercept Pharma Deutschland GmbH
Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The private company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015. | Medical Distributors | Chief Executive Officer Chief Executive Officer | |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Operating Officer | |
Newron Pharmaceuticals US, Inc. | President Director/Board Member Director/Board Member | ||
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The private company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Biotechnology | Director/Board Member Chief Executive Officer | |
STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
Vereinigte Staaten | 32 |
Vereinigtes Königreich | 7 |
Italien | 5 |
Frankreich | 4 |
Schweden | 3 |
Sektoral
Health Technology | 29 |
Consumer Services | 10 |
Finance | 5 |
Commercial Services | 4 |
Distribution Services | 3 |
Operativ
Director/Board Member | 477 |
Corporate Officer/Principal | 207 |
Independent Dir/Board Member | 145 |
Chairman | 112 |
Chief Executive Officer | 71 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Srini Akkaraju Akkaraju | 54 |
Daniel Bradbury | 45 |
Jonathan Silverstein | 42 |
Una Ryan | 38 |
Bo Jesper Hansen | 34 |
Stig Anders Lindberg | 31 |
Joseph deBethizy | 29 |
Gino Santini | 26 |
Daniel Welch | 24 |
Patrick J. Langlois | 23 |
Barbara Duncan | 22 |
Charles Ryan | 22 |
David Lamond | 20 |
Giovanni Rizzo | 20 |
Claudius Rumazza | 20 |
- Börse
- Insiders
- Luca Benatti
- Unternehmensverbindungen